Liangzhu Yu

470 total citations
25 papers, 366 citations indexed

About

Liangzhu Yu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Liangzhu Yu has authored 25 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Liangzhu Yu's work include Pain Mechanisms and Treatments (5 papers), Parathyroid Disorders and Treatments (3 papers) and Ion channel regulation and function (3 papers). Liangzhu Yu is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Parathyroid Disorders and Treatments (3 papers) and Ion channel regulation and function (3 papers). Liangzhu Yu collaborates with scholars based in China and Germany. Liangzhu Yu's co-authors include Mincai Li, Jieqiong Ding, Hongli Xia, Menglin Cheng, Mingyue Li, Haili Zhu, Wenli Liao, Min Xie, Binhua Luo and Qiong Tang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Liangzhu Yu

22 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangzhu Yu China 11 193 82 53 43 37 25 366
Yan-ting Gu China 13 200 1.0× 53 0.6× 33 0.6× 14 0.3× 19 0.5× 26 463
Zahide Çavdar Türkiye 12 134 0.7× 58 0.7× 44 0.8× 16 0.4× 77 2.1× 40 478
Zhen Jin China 15 311 1.6× 57 0.7× 35 0.7× 25 0.6× 36 1.0× 19 540
Jie Fang China 8 213 1.1× 59 0.7× 17 0.3× 36 0.8× 95 2.6× 25 427
Ke‐Xue Li China 12 207 1.1× 63 0.8× 20 0.4× 95 2.2× 47 1.3× 17 465
Tianluo Lei China 12 307 1.6× 146 1.8× 38 0.7× 22 0.5× 85 2.3× 16 622
Jung Eun Kim South Korea 10 150 0.8× 63 0.8× 75 1.4× 30 0.7× 40 1.1× 11 429
M. L. Díez-Marqués Spain 13 222 1.2× 174 2.1× 78 1.5× 63 1.5× 60 1.6× 25 552
Bryan T. Hackfort United States 11 245 1.3× 104 1.3× 17 0.3× 137 3.2× 50 1.4× 19 490

Countries citing papers authored by Liangzhu Yu

Since Specialization
Citations

This map shows the geographic impact of Liangzhu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangzhu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangzhu Yu more than expected).

Fields of papers citing papers by Liangzhu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangzhu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangzhu Yu. The network helps show where Liangzhu Yu may publish in the future.

Co-authorship network of co-authors of Liangzhu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Liangzhu Yu. A scholar is included among the top collaborators of Liangzhu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangzhu Yu. Liangzhu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yin, et al.. (2025). Puerarin Improves Cancer-Induced Bone Pain by Recovering Mitochondrial Dysfunction in the Spinal Cord. Journal of Neuroimmune Pharmacology. 20(1). 67–67.
2.
Yu, Liangzhu, et al.. (2024). Puerarin alleviates oxaliplatin-induced neuropathic pain by promoting Nrf2/GPX4-mediated antioxidative response. PLoS ONE. 19(8). e0308872–e0308872. 8 indexed citations
3.
Li, Qingjie, Suqin Li, Wenli Liao, et al.. (2024). Target analysis and identification of curcumin against vascular calcification. Scientific Reports. 14(1). 17344–17344.
4.
Sun, Xu, Liangzhu Yu, Jieqiong Ding, et al.. (2023). GSK-3β inhibition alleviates arthritis pain via reducing spinal mitochondrial reactive oxygen species level and inflammation. PLoS ONE. 18(4). e0284332–e0284332. 4 indexed citations
5.
Li, Suqin, Qingjie Li, Fei Liu, et al.. (2023). Increased Neuromedin B is Associated with a Favorable Prognosis in Glioblastoma. Frontiers in Bioscience-Landmark. 28(3). 54–54. 3 indexed citations
6.
7.
Li, Suqin, Qingjie Li, Wenli Liao, et al.. (2023). Identification of key genes and pathways in atherosclerosis using integrated bioinformatics analysis. BMC Medical Genomics. 16(1). 102–102. 3 indexed citations
8.
Zhao, Jiajia, Yan Yan, Liangzhu Yu, et al.. (2023). LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response. International Journal of Molecular Medicine. 51(5). 19 indexed citations
9.
Chen, Tao, Liangzhu Yu, Shaohui Chen, et al.. (2023). Xanthohumol relieves arthritis pain in mice by suppressing mitochondrial-mediated inflammation. Molecular Pain. 19. 814405331–814405331. 8 indexed citations
10.
Zhang, Feng, Menglin Cheng, Ji Wu, et al.. (2022). Glycogen synthase kinase‐3β inhibition decreases inflammation and relieves cancer induced bone pain via reducing Drp1‐mediated mitochondrial damage. Journal of Cellular and Molecular Medicine. 26(14). 3965–3976. 13 indexed citations
11.
Xie, Min, Menglin Cheng, Bojun Wang, et al.. (2020). 2-Bromopalmitate attenuates inflammatory pain by maintaining mitochondrial fission/fusion balance and function. Acta Biochimica et Biophysica Sinica. 53(1). 72–84. 16 indexed citations
12.
Shao, Juan, et al.. (2020). Captopril Attenuates the Upregulated Connexin 43 Expression in Artery Calcification. Archives of Medical Research. 51(3). 215–223. 10 indexed citations
13.
Liao, Wenli, et al.. (2020). Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression. Archives of Biochemistry and Biophysics. 689. 108412–108412. 71 indexed citations
14.
Ding, Jieqiong, Qiong Tang, Binhua Luo, et al.. (2019). Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway. European Journal of Pharmacology. 859. 172549–172549. 57 indexed citations
15.
Li, Mingyue, Jieqiong Ding, Qiong Tang, et al.. (2018). SIRT1 activation by SRT1720 attenuates bone cancer pain via preventing Drp1-mediated mitochondrial fission. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(3). 587–598. 49 indexed citations
16.
Yu, Liangzhu, Wei Meng, Jieqiong Ding, & Menglin Cheng. (2016). Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway. Biochemical and Biophysical Research Communications. 473(2). 455–461. 29 indexed citations
17.
Li, Mincai, Suqin Li, Liangzhu Yu, et al.. (2013). Bone Mesenchymal Stem Cells Contributed to the Neointimal Formation after Arterial Injury. PLoS ONE. 8(12). e82743–e82743. 10 indexed citations
18.
Yu, Liangzhu, et al.. (2013). Endothelin-1 Stimulates the Expression of L-Type Ca2+ Channels in Neonatal Rat Cardiomyocytes via the Extracellular Signal–Regulated Kinase 1/2 Pathway. The Journal of Membrane Biology. 246(4). 343–353. 7 indexed citations
19.
Yu, Liangzhu, et al.. (2013). Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism. International Journal of Molecular Medicine. 32(3). 717–722. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan-ting Gu Breakdown of academic impact, for papers by Zahide Çavdar Breakdown of academic impact, for papers by Zhen Jin Breakdown of academic impact, for papers by Jie Fang Breakdown of academic impact, for papers by Ke‐Xue Li Breakdown of academic impact, for papers by Tianluo Lei Breakdown of academic impact, for papers by Jung Eun Kim Breakdown of academic impact, for papers by M. L. Díez-Marqués Breakdown of academic impact, for papers by Bryan T. Hackfort
Rankless by CCL
2026